А. А. Ковалев
Gomel State Medical University · 44 works · 57 citations · h-index 4
Top works
- Assessment of the quality of a binary classifier in research
- Gut microbiota might influence the risk of rejection after liver transplantation
- Микробиом-ассоциированное прогнозирование врожденной пневмонии у недоношенных новорожденных детей
- Comparative immunogenicity and safety of Gam-COVID-Vac and Sinopharm BBIBP-CorV vaccines: results of a pilot clinical study
- Sarcopenia in chronic liver disease, can we predict complications?
- Microbiome-associated biomarkers of pneumonia in premature newborns
- Safety Assessment of Inactivated Whole Virion Booster Vaccine against the SARS-CoV-2 Virus (BelCovidVac) in Immunized Study Subjects aged 18 to 60 Years (day 28)
- Urobiota and urinary tract infections in liver cirrhosis
- Evaluation of Factors Affecting Long-Term Survival after Liver Transplantation
- Микробиом верхних дыхательных путей у недоношенных новорожденных детей при отсутствии врожденной пневмонии: особенности первичного спектра на разных сроках гестации
- Features of the gut microbiota in patients with severe liver fibrosis and cirrhosis associated with chronic hepatitis C
- The «microbiome» of post-liver transplant complications
- Comparison of different DNA detection options for TTV, TTMDV, and TTMV viruses
- Organizational and clinical measures for early detection and diagnosis of pharyngeal mycosis associated with respiratory diseases
- Organizational measures for early detection of pharyngeal mycosis using questionnaires
- Analysis of the effectiveness of COVID-19 coronavirus vaccination in patients with chronic heart failure at the outpatient stage of treatment
- Efficacy of COVID-19 vaccination in organized group: results of a prospective study
- Некоторые проблемы обучения методам статистического анализа данных и возможности современных информационных технологий для их решения
- Analysis of suicidal activity in the population of Gomel region over a period of 2018–2024
- Immunological effectiveness of the booster Soberana Plus vaccine (FINLAY-FR-1A)